AV Favipiravir

Aus coViki
Wechseln zu: Navigation, Suche
  • GET 2006. Favipiravir Extract
  • GET ä. Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study Extract
  • GET 2020. Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019-nCoV Infection Extract
  • GET 2020. Dose Rationale for Favipiravir Use in Patients Infected With SARS-CoV-2 Extract
  • GET ä. Potential repurposing of Favipiravir in COVID-19 outbreak based on current evidence Extract
  • GET 2020. Pharmacokinetics of Favipiravir in Critically Ill Patients with COVID-19. Extract
  • GET 2020. Favipiravir, an antiviral for COVID-19? Extract
  • GET 2020. A Case of Successful Treatment of Severe COVID-19 Pneumonia with Favipiravir and Tocilizumab in Post-kidney Transplant Recipient. Extract
  • GET 2020. Uric Acid Elevation by Favipiravir, an Antiviral Drug. Extract
  • GET 2020. A review of the safety of favipiravir - a potential treatment in the COVID-19 pandemic? Extract
  • GET 2020. Response to "Dose Rationale for Favipiravir Use in Patients Infected With SARS-CoV-2". Extract
Meine Werkzeuge